Drug
Bim 23a760
Bim 23a760: highest development phase Phase 2, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIM 23A760 NCT00994214 | Phase 2 | Acromegaly |
Latest
No recent events.
Follow Bim 23a760 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.